Medical devices, healthcare technology and the business of care
PMA approval · P160026

LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

Physio-Control, Inc. · Decision date Jul 2, 2018

MEDTECHLEDGER EXPLANATIONP160026

What did the FDA approve?

FDA approved a PMA supplement from Physio-Control, Inc. covering the LIFEPAK 1000 defibrillator, the LIFEPAK 1000 lithium-ion rechargeable battery, refurbished LIFEPAK 20 defibrillator/monitors, the LIFEPAK 20e defibrillator/monitor, the LIFEPAK 15 monitor/defibrillator, and the LIFEPAK lithium-ion rechargeable battery for use with the LIFEPAK 15. The decision date is July 2, 2018, and the product code is MKJ under the cardiovascular specialty.

The statement lists AED-mode indications. The LIFEPAK 1000 is for patients in cardiopulmonary arrest who are unresponsive, not breathing normally, and showing no signs of circulation; it may be used on adults and children 8 years or older or over 25 kg, and on younger or lighter children with Infant/Child Reduced Energy Defibrillation Electrodes. The LIFEPAK 20, 20e, and 15 AED modes are for unconscious, pulseless patients not breathing normally, and are not intended for pediatric patients under 8 years old. The statement does not describe the specific change covered by the supplement.

FDA approval order statement

Approval for the LIFEPAK 1000 Defibrillator, LIFEPAK 1000 Defibrillator Lithium-ion Rechargeable Battery, LIFEPAK 20 Defibrillator/ Monitor (Refurbished), LIFEPAK 20e Defibrillator/ Monitor, LIFEPAK 15 Monitor/Defibrillator, and LIFEPAK Lithium-ion Rechargeable Battery (for use with the LIFEPAK 15 Monitor/Defibrillator) These devices are indicated for use as follows:LIFEPAK 1000 DefibrillatorThe defibrillator is to be used in AED mode only on patients who are in cardiopulmonary arrest. The patient must be unresponsive, not breathing normally, and showing no signs of circulation. The defibrillator may be used with standard defibrillation pads only on adults and children who are 8 years old or more or who weigh more than 25 kg (55 lbs). The defibrillator may be used on children who are less than 8 years old or weigh less than 25 kg (55 lbs) with Infant/Child Reduced Energy Defibrillation Electrodes.LIFEPAK 20/20e Defibrillator/Monitors The AED mode is to be used only on patients in cardiopulmonary arrest. The patient must be unconscious, pulseless, and not breathing normally before using the defibrillator to analyze the patients ECG rhythm. In AED mode, the LIFEPAK 20 and LIFEPAK 20e defibrillator/monitor is not intended for use on pediatric patients less than 8 years old. LIFEPAK 15 Defibrillator/Monitors AED mode is to be used only on patients in cardiopulmonary arrest. The patient must be unconscious, pulseless, and not breathing normally before using the defibrillator to analyze the patients ECG rhythm. In AED mode, the LIFEPAK 15 monitor/defibrillator is not intended for use on pediatric patients less than 8 years old.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jul 2, 2018

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160026
Regulatory pathway
Premarket approval application
Product code
MKJ
Decision code
APPR
Decision date
Jul 2, 2018
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P160026 received

    Application receipt date recorded by FDA.

  2. P160026 · FDA decision

    APPR

  3. P160026/S069 · Related supplement

    LIFEPAK 35 monitor/defibrillator

  4. P160026/S073 · Related supplement

    LIFEPAK 15 monitor/defibrillator

  5. P160026/S074 · Related supplement

    LIFEPAK 1000 DEFIBRILLATOR, LIFEPAK 20 DEFIBRILLATOR/ MONITOR, LIFEPAK 20E DEFIBRILLATOR/ MONITOR, LIFEPAK 15 MONITOR/DE

  6. P160026/S076 · Related supplement

    LIFEPAK 35 monitor/defibrillator

Timeline entries are records held by MedtechLedger for P160026. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160026

Product / regulatory recordCompanyPathwayDecision dateSource
Physio-Control, Inc.PMA supplementSep 2, 2026FDA
Physio-Control, Inc.PMA supplementSep 10, 2026FDA
Physio-Control, Inc.PMA supplementSep 24, 2026FDA
Physio-Control, Inc.PMA supplementOct 29, 2026FDA

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Physio-Control, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
11811 Willows Rd. NE, Redmond, WA, 98052

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records